Colgate-Palmolive COO sells 19,938 shares
The COO sold the same 19,938 shares acquired through the option exercise, at prices ranging from $98.585 to $98.97.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Colgate-Palmolive (CL) COO Panagiotis Tsourapas exercised 19,938 stock options on November 4, 2026, at a $76.41 exercise price, acquiring 19,938 common shares. Tsourapas sold 19,938 shares the same day at a weighted average price of $98.7415; sale prices ranged from $98.585 to $98.97. A portion of the sale proceeds was delivered to the issuer for payment of the exercise price and related tax withholding.
The reported post-transaction option balance was 0. Separate indirect common-stock holdings were 4,645 shares by the issuer's 401(k) Plan Trustee and 67,237 shares by a trust; the trust amount includes 2,336 shares previously reported as directly beneficially owned.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F5 | 19,938 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 19,938 | $76.41 | $1.52M |
| Sale | Common Stock F2, F3 | 19,938 | $98.7415 | $1.97M |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F4 | -- | -- | -- |
Footnotes (5)
- F1. Exercise of stock options awarded under the issuer's incentive compensation plan.
- F2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
- F3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $98.585 to $98.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. This amount includes 2,336 shares that were previously reported as directly beneficially owned.
- F5. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.
Key Figures
Key Terms
stock options financial
incentive compensation plan financial
weighted average price financial
tax withholding financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When did the CL options become exercisable?
AI-generated analysis. How Rhea-AI works. Not financial advice.